相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
for future use below -18°C
- 保质期:
See instructions
- 英文名:
CD20
- 库存:
常规产品有备货
- 供应商:
上海经科化学科技有限公司
- CAS号:
无
- 规格:
50ug/0.5mg/1mg
| 规格: | 50ug | 产品价格: | ¥2415.0 |
|---|---|---|---|
| 规格: | 0.5mg | 产品价格: | ¥14800.0 |
| 规格: | 1mg | 产品价格: | ¥28980.0 |

CATALOGUE NUMBER
ANT-191
SYNONYMS
TYPE
INTRODUCTION
DESCRIPTION
CD-20 is purified by proprietary chromatographic techniques.
SOURCE
PHYSICAL APPEARANCE
FORMULATION
SOLUBILITY
STABILITY
Upon reconstitution CD20 Antibody should be stored at 4°C between 2-7 days and for future use below -18°C.
For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).
Please prevent freeze-thaw cycles.
PURITY
Analysis by RP-HPLC.
Analysis by SDS-PAGE gel.
BIOLOGICAL ACTIVITY
SAFETY DATA SHEET
SDS
USAGE
ProSpec's products are furnished for LABORATORY RESEARCH USE ONLY. They may not be used as drugs,agricultural or pesticidal products, food additives or household chemicals.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验CD20 is a member of the membrane-spanning 4A gene family. Members of this nascent protein family are characterized by common structural features and similar intron/exon splice boundaries and display unique expression patterns among hematopoietic cells and nonlymphoid tissues. CD20 plays a role in the development and differentiation of B-cells into plasma cells. CD20 is localized to 11q12, among a cluster of family members. Alternative splicing of this gene results in two transcript variants which encode the same protein.
a simple ELISA method to detect human anti-antibody response.
membrane, creating a structure similar to an ion channel Delivers early signal in B cell activation, allowing resting B cells to respond to later antigens Rituximab is a chimeric murine-human anti-CD20 antibody used for treatment of B cell
Recombinant Adenoviruses for In Vivo Expression of Antibody Fragments
A growing number of recombinant antibodies is being developed for immunotherapy of cancer (1 ,2 ) (see also Chapter 2 ). Although these recombinant antibodies can exhibit a potent anti-tumoral activity in vitro, efficacy in vivo
技术资料






](https://img1.dxycdn.com/p/s14/2024/0416/172/6503900736202610871.jpg!wh200)
